338 related articles for article (PubMed ID: 24994608)
1. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension.
Raptis AE; Markakis KP; Mazioti MC; Ikonomidis I; Maratou EP; Vlahakos DV; Kotsifaki EE; Voumvourakis AN; Tsirogianni AG; Lambadiari VA; Lekakis JP; Raptis SA; Dimitriadis GD
Am J Hypertens; 2015 Jan; 28(1):22-9. PubMed ID: 24994608
[TBL] [Abstract][Full Text] [Related]
2. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
Virdis A; Ghiadoni L; Qasem AA; Lorenzini G; Duranti E; Cartoni G; Bruno RM; Bernini G; Taddei S
Eur Heart J; 2012 Jun; 33(12):1530-8. PubMed ID: 22450428
[TBL] [Abstract][Full Text] [Related]
3. Role of aliskiren on arterial stiffness and endothelial function in patients with primary hypertension.
Bonadei I; Vizzardi E; D'Aloia A; Sciatti E; Raddino R; Metra M
J Clin Hypertens (Greenwich); 2014 Mar; 16(3):202-6. PubMed ID: 24708382
[TBL] [Abstract][Full Text] [Related]
4. Effect of aliskiren on arterial stiffness, compared with ramipril in patients with mild to moderate essential hypertension.
Guo JQ; Wang HY; Sun NL
Chin Med J (Engl); 2013 Apr; 126(7):1242-6. PubMed ID: 23557551
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients.
Okada Y; Shibata S; Fujimoto N; Best SA; Levine BD; Fu Q
Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R400-R409. PubMed ID: 28724547
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
Koumaras C; Tziomalos K; Stavrinou E; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of aliskiren/amlodipine combination and high-dose amlodipine monotherapy on endothelial function in elderly hypertensive patients.
Fukutomi M; Hoshide S; Mizuno H; Kario K
Am J Hypertens; 2014 Jan; 27(1):14-20. PubMed ID: 24008122
[TBL] [Abstract][Full Text] [Related]
8. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.
Lambadiari V; Pavlidis G; Kousathana F; Varoudi M; Vlastos D; Maratou E; Georgiou D; Andreadou I; Parissis J; Triantafyllidi H; Lekakis J; Iliodromitis E; Dimitriadis G; Ikonomidis I
Cardiovasc Diabetol; 2018 Jan; 17(1):8. PubMed ID: 29310645
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect ∼ a pilot study∼.
Moriya H; Kobayashi S; Ohtake T; Tutumi D; Mochida Y; Ishioka K; Oka M; Maesato K; Hidaka S; Nomura S
Kidney Blood Press Res; 2013; 37(2-3):190-8. PubMed ID: 23736778
[TBL] [Abstract][Full Text] [Related]
11. Effects of a long-term treatment with aliskiren or ramipril on structural alterations of subcutaneous small-resistance arteries of diabetic hypertensive patients.
De Ciuceis C; Savoia C; Arrabito E; Porteri E; Mazza M; Rossini C; Duse S; Semeraro F; Agabiti Rosei C; Alonzo A; Sada L; La Boria E; Sarkar A; Petroboni B; Mercantini P; Volpe M; Rizzoni D; Agabiti Rosei E
Hypertension; 2014 Oct; 64(4):717-24. PubMed ID: 24980672
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naïve patients of hypertension.
Kwon BJ; Jang SW; Choi KY; Kim DB; Cho EJ; Ihm SH; Youn HJ; Kim JH
Hypertens Res; 2013 Jan; 36(1):79-84. PubMed ID: 23034468
[TBL] [Abstract][Full Text] [Related]
13. Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
Liu Y; Yan R; Song A; Niu X; Cao C; Wei J; Dong X; Gao D
Am J Hypertens; 2014 Feb; 27(2):268-78. PubMed ID: 24304656
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren directly improves endothelial progenitor cell function from Type II diabetic patients.
Chang TT; Wu TC; Huang PH; Chen JS; Lin LY; Lin SJ; Chen JW
Eur J Clin Invest; 2016 Jun; 46(6):544-54. PubMed ID: 27062013
[TBL] [Abstract][Full Text] [Related]
15. Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.
Kanaoka T; Tamura K; Ohsawa M; Wakui H; Maeda A; Dejima T; Azushima K; Haku S; Mitsuhashi H; Yanagi M; Oshikawa J; Uneda K; Aoki K; Fujikawa T; Toya Y; Uchino K; Umemura S
J Clin Hypertens (Greenwich); 2012 Aug; 14(8):522-9. PubMed ID: 22863160
[TBL] [Abstract][Full Text] [Related]
16. Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.
Fogari R; Mugellini A; Zoppi A; Preti P; Maffioli P; Perrone T; Derosa G
Expert Opin Pharmacother; 2013 Mar; 14(4):371-84. PubMed ID: 23414196
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Bush C; Keefe DL
J Hypertens; 2009 Jul; 27(7):1493-501. PubMed ID: 19444142
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study.
Spanos G; Kalaitzidis R; Karasavvidou D; Pappas K; Siamopoulos KC
J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):315-21. PubMed ID: 23132848
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
[TBL] [Abstract][Full Text] [Related]
20. Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study.
Basile J; Babazadeh S; Lillestol M; Botha J; Yurkovic C; Weitzman R
J Clin Hypertens (Greenwich); 2011 Mar; 13(3):162-9. PubMed ID: 21366847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
